Abstract
First cases that point at a correlation between SARS-CoV-2 infections and the development of Parkinson’s disease (PD) have been reported. Currently, it is unclear if there is also a direct causal link between these diseases. To obtain first insights into a possible molecular relation between viral infections and the aggregation of α-synuclein protein into amyloid fibrils characteristic for PD, we investigated the effect of the presence of SARS-CoV-2 proteins on α-synuclein aggregation. We show, in test tube experiments, that SARS-CoV-2 spike protein (S-protein) has no effect on α-synuclein aggregation, while SARS-CoV-2 nucleocapsid protein (N-protein) considerably speeds up the aggregation process. We observe the formation of multiprotein complexes and eventually amyloid fibrils. Microinjection of N-protein in SH-SY5Y cells disturbed the α-synuclein proteostasis and increased cell death. Our results point toward direct interactions between the N-protein of SARS-CoV-2 and α-synuclein as molecular basis for the observed correlation between SARS-CoV-2 infections and Parkinsonism.
Original language | English |
---|---|
Pages (from-to) | 143-150 |
Number of pages | 8 |
Journal | ACS chemical neuroscience |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published - 5 Jan 2022 |
Keywords
- amyloids
- Covid-19
- neurodegeneration
- Parkinson’s disease
- protein aggregation
- SARS-CoV-2
- UT-Hybrid-D
- Parkinson's disease